Category: HeartWare International Inc.
HeartWare shares come under pressure after the medical device company reports higher-than-expected losses for the 4th quarter and 2013.
Investors punished HeartWare International (NSDQ:HTWR) today for missing expectations with its 4th-quarter and full-year results, paring some 3% from HTWR shares.
HeartWare International's 4th-quarter preliminary sales numbers miss the mark on Wall Street, prompting investors to send its share price down.
HeartWare International (NSDQ:HTWR) said it expects to report 4th-quarter revenues of roughly $53 million, missing the consensus view on Wall Street of $58 million and sending its share price down sharply in pre-market trading.
HeartWare CEO Doug Godshall tells MassDevice.com about the 6-year journey to the $350 million acquisition of heart pump maker CircuLite.
HeartWare International acquires CircuLite in a cash-and-stock deal that could eventually be worth up to $350 million.
Shares of Thoratec Corp. slide after the New England Journal of Medicine publishes results showing a sharp increase in rates of blood clots in patients implanted with the medical device company's HeartMate II left ventricular assist device.
Thoratec (NSDQ:THOR) shares are under pressure after a New England Journal of Medicine study showing a sharp increase in the rate of thrombosis, or blood clots, in patients implanted with its HeartMate II left ventricular assist device.
HeartWare's stock gains 15% after its 3rd-quarter results crush sales and earnings forecasts on higher-than-expected sales of its heart pump.
HeartWare International (NSDQ:HTWR) shares gained 15% this morning after the medical device company crushed forecasts with its 3rd-quarter sales and earnings figures, reporting stronger-than-expected sales of its left ventricular assist device implantable heart pump.
HeartWare International plans to enroll a new arm of patients into its ongoing ENDURANCE clinical trial, this time confirming previous findings that suggest that more blood pressure management can help stem "neurological events."